Abstract
The purpose of this study was to assess the cost-effectiveness of a novel, fluoroscopy-based robotic-assisted total hip arthroplasty (RA-THA) system compared to a manual unassisted technique (mTHA) up to 5years post-operatively. A Markov model was constructed to compare the cost-effectiveness of RA-THA and mTHA. Cost-effectiveness was defined as an Incremental Cost-Effectiveness Ratio (ICER) <$50000 or $100000 per Quality Adjusted Life Year (QALY). RA-THA patients experienced lower costs compared to mTHA patients at 1year ($20865.12±9897.52 vs. $21660.86±9909.15; p<0.001) and 5years ($23124.57±10045.48 vs. $25756.42±10091.84; p<0.001) post-operatively. RA-THA patients also accrued more QALYs (1-year: 0.901±0.117 vs. 0.888±0.114; p<0.001; 5-years: 4.455±0.563 vs. 4.384±0.537 p<0.001). Overall, RA-THA was cost-effective (1-year ICER: $-61210.77; 5-year ICER: $-37068.31). The novel, fluoroscopy-based RA-THA system demonstrated cost-effectiveness when compared to manual unassisted THA.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
